Authorized purpose: Multimodality DICOM image management, quantitative analysis, optional cardiovascular MR mapping and flow analysis, and therapy-response lesion tracking for trained clinicians.
Clinical role
Adjunct image viewer and analysis tool; the FDA labeling says it does not directly generate a diagnosis or finding.
Images and patients
Radiological images; modality varies or is not specified in FDA list · Multi-region
Key limitation
Keep in mind: Requires trained healthcare professionals and user review; optional cardiovascular MR was tested at 1.5T and 3.0T; optional modules and third-party algorithms are not all part of this exact submission.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Multimodality DICOM image management, quantitative analysis, optional cardiovascular MR mapping and flow analysis, and therapy-response lesion tracking for trained clinicians.
Which images or clinical context are in scope?Modality: Radiological images; modality varies or is not specified in FDA list Anatomy or clinical context: Multi-region Input: DICOM and non-DICOM radiological images, including multi-slice and multi-phase CT, MR, ultrasound, x-ray and mammography studies; optional cardiovascular MR includes velocity-encoded data.
Who uses it?Intended users: Trained healthcare professionals, including radiology and cardiovascular imaging users.
What does the software produce?Output: Cloud image display with 2D, 3D and MIP views, measurements, reports, secondary capture, optional T1/T2 and 4D-flow cardiovascular MR outputs, and lesion tracking or Lung-RADS reporting workflows.
What is its most important limitation?Key limitation: Requires trained healthcare professionals and user review; optional cardiovascular MR was tested at 1.5T and 3.0T; optional modules and third-party algorithms are not all part of this exact submission.
Clinical takeaway. Clinical role: Multimodality DICOM image management, quantitative analysis, optional cardiovascular MR mapping and flow analysis, and therapy-response lesion tracking for trained clinicians.
Evidence takeaway. Evidence from the reviewed source record: FDA-reviewed non-clinical T1/T2 inline-map and workflow validation supports the exact release; the FDA summary states there was no clinical study for the modified device.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Multimodality DICOM image management, quantitative analysis, optional cardiovascular MR mapping and flow analysis, and therapy-response lesion tracking for trained clinicians.
DICOM and non-DICOM radiological images, including multi-slice and multi-phase CT, MR, ultrasound, x-ray and mammography studies; optional cardiovascular MR includes velocity-encoded data.
Cloud image display with 2D, 3D and MIP views, measurements, reports, secondary capture, optional T1/T2 and 4D-flow cardiovascular MR outputs, and lesion tracking or Lung-RADS reporting workflows.
Requires trained healthcare professionals and user review; optional cardiovascular MR was tested at 1.5T and 3.0T; optional modules and third-party algorithms are not all part of this exact submission.
FDA-reviewed non-clinical T1/T2 inline-map and workflow validation supports the exact release; the FDA summary states there was no clinical study for the modified device.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
FDA-reviewed non-clinical T1/T2 inline-map and workflow validation supports the exact release; the FDA summary states there was no clinical study for the modified device.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
T1/T2 inline map validation
DesignNon-clinical comparative bench validation
Population30 cardiovascular MR series across manufacturer and scanner types, with four regions of interest per series
Scopeexact submission
Tested versionTempus Pixel release reviewed in K252539
Samplen=30
IndependenceSponsor or vendor study
K252539 FDA 510(k) summary
The FDA summary reports software verification and validation passed and states no clinical study was performed for the modified device.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
Not established in reviewed sources
Reviewed sources checked
Exact FDA submission
Checked 2026-09-04
No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.
Pricing & contractsPublic price, contract terms, and reimbursement
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: DICOM and non-DICOM radiological images, including multi-slice and multi-phase CT, MR, ultrasound, x-ray and mammography studies; optional cardiovascular MR includes velocity-encoded data.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: FDA materials describe upload from PACS or scanner and report/secondary-capture workflows; the Tempus family material was readable during the Sept 7 review and describes PACS, EHR, worklist, notification and dictation integration, but does not establish the exact K252539 configuration. A later automated request returned HTTP 429, which is treated as rate limiting rather than absence of product information.
Scope: Product family.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Source context, not route validation: The reviewed FDA summary describes a completely hosted cloud application accessed through Chrome on standard computers and displays.
Scope: Exact FDA submission.
Confirm processing location, queue ownership, exclusions and exact AI build.
Source context, not route validation: Cloud image display with 2D, 3D and MIP views, measurements, reports, secondary capture, optional T1/T2 and 4D-flow cardiovascular MR outputs, and lesion tracking or Lung-RADS reporting workflows.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: Cloud image display with 2D, 3D and MIP views, measurements, reports, secondary capture, optional T1/T2 and 4D-flow cardiovascular MR outputs, and lesion tracking or Lung-RADS reporting workflows.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
FDA materials describe upload from PACS or scanner and report/secondary-capture workflows; the Tempus family material was readable during the Sept 7 review and describes PACS, EHR, worklist, notification and dictation integration, but does not establish the exact K252539 configuration. A later automated request returned HTTP 429, which is treated as rate limiting rather than absence of product information.
Tempus's responsible disclosure policy commits to vulnerability intake for any of its assets (tempus.com and public internet-facing and cloud infrastructure it operates), coordinated handling with a 90-day disclosure window, timely correction, and a safe-harbor commitment for good-faith research. Arterys' own site states Arterys has joined Tempus as Tempus Radiology.
Vendor-wide
Checked 2026-10-27
Vendor statement. Entity bridge: arterys.com announces 'Arterys has joined Tempus... as Tempus Radiology'. The Tempus policy is an organizational vulnerability-handling statement; no certification or audit report was read, and exact-release scope is not established. Applicant name variant 'Arterys, Inc.' is bridged to Arterys, Inc. via the identical distinctive name and Arterys product naming.
Tempus' responsible disclosure policy, covering Tempus assets and operated infrastructure, states vulnerability intake with a 90-day coordinated disclosure window and a timely correction commitment.
Vendor-wide
Checked 2026-10-27
Vendor statement, not an attestation. The policy names Tempus generally and does not scope these commitments to any specific product release; exact-release scope is not established.
Current Tempus Pixel family material describes PACS, EHR, worklist, notification and dictation integration; exact K252539 configuration is not established.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Human reviewedStatus
2026-09-07Last searched
24Fields reviewed
11Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
The stored candidate metadata contained empty PubMed and clinical-trial ID arrays; metadata was screened, not full-text or registry-reviewed. The stored recall candidate record was empty and no event was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, vendor product page, vendor manual, peer reviewed publication, clinical trial registry, recall database, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not publicly available - checked 2026-09-07 - Exact FDA submission
No numeric price was published in the reviewed sources.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not publicly available - checked 2026-10-26 - Exact FDA submission
Bounded web search on 2026-10-26 (query: "Tempus Pixel Arterys reimbursement CPT"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. This records what was found, not that none exists.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Installation timeline: Not yet reviewed
Training: Not verified - checked 2026-10-27 - Exact FDA submission
Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
Authorized purpose: Contour ProtégéAI+ processes CT and MR DICOM images and generates contours for quantitative analysis, adaptive therapy, image registration, transfer to radiotherapy planning, and archiving subject to qualified review and editing.
Modality
Radiological images; modality varies or is not specified in FDA list
Authorized purpose: Synapse PACS version 7.5 provides primary processing and presentation of DICOM and supported non-DICOM images with measurement, segmentation, fusion, volume rendering, reporting, integrated 3D, two-point VOI, and AI-assisted bone removal.
Modality
Radiological images; modality varies or is not specified in FDA list
Authorized purpose: CT and MR 3D segmentation, measurements and interactive models for adult preoperative and intraoperative surgical planning; not primary diagnosis.
Modality
Radiological images; modality varies or is not specified in FDA list
Authorized purpose: Ziostation2 is customer-hardware image-processing software for viewing, quantifying, manipulating, communicating, printing, and managing many radiological image types, with release-specific tools for lung and bronchoscopy planning, cardiac MR T1 mapping, and other advanced visualization.
Modality
Radiological images; modality varies or is not specified in FDA list
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.